Daré Bioscience (DARE) Stock Chart & Stock Price History → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free DARE Stock Alerts $0.41 -0.02 (-4.65%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Daré Bioscience Stock Price Performance5 Day Performance+0.47%1 Month Performance+31.41%3 Month Performance-25.44%6 Month Performance+15.17%Year-To-Date Performance+32.69%1 Year Performance-59.80% Receive DARE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Daré Bioscience and its competitors with MarketBeat's FREE daily newsletter Email Address Ad The Freeport SocietyBill Clinton Backing Biden Replacement???Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast. DARE Stock Chart for Sunday, June, 2, 2024 DARE Chart by TradingView Daré Bioscience Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.43$0.41-4.78%$0.43$0.41186,935 shs$41.45 million05/30/2024$0.47$0.43-8.38%$0.48$0.42406,824 shs$43.53 million05/29/2024$0.41$0.47+15.17%$0.50$0.401.21 million shs$47.51 million05/28/2024$0.44$0.41-6.40%$0.43$0.40347,426 shs$41.26 million05/27/2024$0.44$0.44$0.47$0.40557,000 shs$44.08 million05/24/2024$0.45$0.44-4.09%$0.47$0.40556,937 shs$44.08 million Get the Latest News and Ratings for DARE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Daré Bioscience and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.40$0.45+13.65%$0.45$0.41419,012 shs$45.96 million05/22/2024$0.42$0.40-5.75%$0.41$0.38491,656 shs$40.44 million05/21/2024$0.61$0.42-30.43%$0.63$0.402.06 million shs$42.90 million05/20/2024$0.49$0.61+25.70%$0.62$0.481.40 million shs$61.67 million05/17/2024$0.43$0.49+11.61%$0.49$0.43928,482 shs$49.06 million05/16/2024$0.36$0.43+20.78%$0.45$0.37917,097 shs$43.73 million05/15/2024$0.32$0.36+14.29%$0.39$0.332.12 million shs$36.21 million05/14/2024$0.32$0.32-0.82%$0.33$0.31409,352 shs$31.68 million05/13/2024$0.31$0.32+2.29%$0.32$0.31177,531 shs$31.94 million05/10/2024$0.31$0.31-0.99%$0.33$0.31233,731 shs$31.23 million05/09/2024$0.31$0.31+2.12%$0.32$0.30134,700 shs$31.54 million05/08/2024$0.31$0.31-0.94%$0.32$0.30225,117 shs$30.89 million05/07/2024$0.31$0.31+1.31%$0.32$0.30182,691 shs$31.18 million05/06/2024$0.31$0.31-1.67%$0.32$0.30255,750 shs$30.78 million05/03/2024$0.31$0.31-0.26%$0.32$0.30335,223 shs$31.30 million05/02/2024$0.33$0.31-5.43%$0.33$0.30967,021 shs$31.38 million05/01/2024$0.31$0.33+7.28%$0.39$0.311.82 million shs$33.18 million04/30/2024$0.28$0.31+9.08%$0.39$0.2811.95 million shs$30.93 million04/29/2024$0.31$0.28-7.85%$0.31$0.28172,555 shs$28.35 million04/26/2024$0.29$0.31+5.77%$0.31$0.29175,001 shs$30.77 million04/25/2024$0.29$0.29+1.12%$0.29$0.28325,147 shs$29.09 million04/24/2024$0.30$0.29-3.80%$0.29$0.28415,941 shs$28.77 million04/23/2024$0.30$0.30+0.68%$0.32$0.29322,438 shs$29.90 million04/22/2024$0.28$0.30+5.46%$0.30$0.28161,690 shs$29.70 million04/19/2024$0.30$0.28-5.12%$0.31$0.28553,915 shs$28.16 million04/18/2024$0.28$0.30+4.39%$0.31$0.29974,742 shs$29.68 million04/17/2024$0.48$0.28-41.70%$0.48$0.284.23 million shs$28.43 million04/16/2024$0.48$0.48+1.00%$0.49$0.4894,901 shs$48.77 million04/15/2024$0.47$0.48+2.28%$0.48$0.46203,551 shs$48.29 million04/12/2024$0.48$0.47-2.61%$0.49$0.4685,340 shs$47.21 million04/11/2024$0.48$0.48+0.71%$0.49$0.46228,425 shs$48.48 million04/10/2024$0.47$0.48+1.61%$0.48$0.46137,000 shs$48.14 million04/09/2024$0.50$0.47-5.67%$0.52$0.47159,327 shs$47.37 million04/08/2024$0.49$0.50+1.65%$0.51$0.49168,465 shs$50.22 millionHow Biden has already won 2024 (Ad)Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. 04/05/2024$0.51$0.49-3.50%$0.51$0.47306,449 shs$49.41 million04/04/2024$0.48$0.51+5.71%$0.51$0.49161,147 shs$51.20 million04/03/2024$0.49$0.48-2.21%$0.50$0.47134,176 shs$48.43 million04/02/2024$0.50$0.49-0.55%$0.50$0.47197,182 shs$48.53 million04/01/2024$0.49$0.50+1.00%$0.52$0.48342,821 shs$48.80 million03/29/2024$0.49$0.49$0.56$0.49559,623 shs$48.31 million03/28/2024$0.55$0.49-10.71%$0.56$0.49556,434 shs$48.31 million03/27/2024$0.50$0.55+10.17%$0.55$0.49296,654 shs$54.11 million03/26/2024$0.52$0.50-3.24%$0.53$0.49157,330 shs$49.11 million03/25/2024$0.48$0.52+7.65%$0.53$0.48439,298 shs$50.76 million03/22/2024$0.48$0.48+0.72%$0.49$0.45118,261 shs$47.15 million03/21/2024$0.46$0.48+2.61%$0.50$0.46217,655 shs$46.82 million03/20/2024$0.51$0.46-9.24%$0.53$0.431.00 million shs$45.62 million03/19/2024$0.51$0.51$0.53$0.50119,843 shs$50.27 million03/18/2024$0.47$0.51+8.88%$0.53$0.47329,651 shs$50.27 million03/15/2024$0.46$0.47+2.90%$0.48$0.45148,682 shs$46.17 million03/14/2024$0.46$0.46-1.11%$0.48$0.45167,303 shs$44.87 million03/13/2024$0.46$0.46+0.04%$0.48$0.45136,855 shs$45.37 million03/12/2024$0.50$0.46-8.04%$0.52$0.45189,935 shs$45.35 million03/11/2024$0.50$0.50+1.05%$0.52$0.50106,402 shs$49.31 million03/08/2024$0.49$0.50+0.43%$0.52$0.49223,426 shs$48.80 million03/07/2024$0.51$0.49-4.01%$0.52$0.48342,652 shs$48.59 million03/06/2024$0.56$0.51-8.77%$0.55$0.50387,036 shs$50.62 million03/05/2024$0.55$0.56+2.35%$0.58$0.53365,647 shs$55.49 million03/04/2024$0.55$0.55+0.04%$0.57$0.48461,984 shs$54.22 million03/01/2024$0.57$0.55-4.20%$0.59$0.54564,174 shs$54.20 million Related Companies: Alimera Sciences Stock Price Chart Rigel Pharmaceuticals Stock Price Chart Veru Stock Price Chart Sagimet Biosciences Stock Price Chart Context Therapeutics Stock Price Chart Cartesian Therapeutics Stock Price Chart ProQR Therapeutics Stock Price Chart InterCure Stock Price Chart Rezolute Stock Price Chart Cybin Stock Price Chart Receive DARE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Daré Bioscience and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DARE) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…StocksToTradeTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daré Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.